TOBY Completes Nashville Entrepreneur Center's Project Healthcare Accelerator

BOSTON, July 15, 2025 /PRNewswire/ -- TOBY, Inc., a leader in noninvasive multi-cancer detection, has successfully completed the Nashville Entrepreneur Center's Project Healthcare accelerator. This four-month program, known for its deep integration with Nashville's healthcare ecosystem, provided TOBY with strategic mentorship, industry connections, and access to key stakeholders, enhancing its readiness for market entry.

Project Healthcare, now in its seventh year, is designed to support high-growth healthcare startups by offering a tailored curriculum and connections to Nashville's extensive network of healthcare organizations, including seven of the nation's largest health systems. As an HCA Healthcare Scholar in the cohort, TOBY's participation in this program has been influential in refining its go-to-market strategy and expanding its network within the healthcare industry.

"Project Healthcare provided us with access to healthcare leaders and insights that have been critical in shaping our commercialization strategy," said Matthew Laskowski, CEO of TOBY. "The program's emphasis on real-world application and industry immersion has positioned us to effectively bring our innovative cancer detection solution to the market."

TOBY's platform utilizes advanced gas chromatography–mass spectrometry and proprietary AI models to analyze volatile organic compounds (VOCs) in urine, enabling the detection of multiple cancers with high sensitivity and specificity. This noninvasive approach offers a patient-friendly alternative to traditional screening methods.

"TOBY is exactly the kind of company we seek to enroll in Project Healthcare. Matthew and his team leveraged our resources and curriculum to further the success they had already built prior to working with us," said Sam Davidson, chief executive officer, Nashville Entrepreneur Center. "We're excited to see where they go next as they continue to innovate within the industry."

With the completion of Project Healthcare, TOBY is poised to advance its clinical validation studies and submissions, bringing its innovative cancer detection solution closer to widespread clinical adoption.

In addition to Project Healthcare, TOBY participated in the MassChallenge U.S. Early Stage Accelerator and the LifeX Life Sciences Commercialization Accelerator. The company also earned the Massachusetts AI Health Innovation Grant, where the Cambridge Innovation Center (CIC) assisted in software development efforts, was selected for McDermott Will & Emery's competitive LEAP Program, and won first prize at ADLM 2024, placing it first among nearly 100 biotech startups.

To learn more, visit Toby.health.

About TOBY, Inc.:

TOBY, inspired by after Sherlock Holmes's Bloodhound, is a BioTech startup focused on the early detection of cancer utilizing spectroscopy and Artificial Intelligence. TOBY has developed a single urine test that detects 10 cancers, representing over 60% of all new cases globally. This test identifies the unique molecular signature of cancer by combining the precision of spectroscopy, changes in biomarkers (VOCs), and cutting-edge computational algorithms to deliver early, easy, and affordable cancer screening.

View original content to download multimedia:https://www.prnewswire.com/news-releases/toby-completes-nashville-entrepreneur-centers-project-healthcare-accelerator-302505797.html

SOURCE TOBY, Inc.